Most people never see what happens after a pill is swallowed. The medicine is taken, symptoms ease, and life moves on.
But for patients with weakened immune systems, treatment can be far from straightforward. When viruses stop responding to standard drugs, infections can turn dangerous, fast.
That challenge has driven scientists to look closer than ever before at how viruses actually operate inside the body.
Watching a virus in action
Researchers at Harvard Medical School have now managed to observe, in real time, how a new class of antiviral drugs disrupts the herpes simplex virus as it attempts to replicate.
Also read: Why healthy January resolutions are so hard to maintain
The work was led by infectious disease specialist Jonathan Abraham in collaboration with molecular pharmacologist Joseph Loparo.
Herpes viruses are persistent by nature. They can remain dormant for years and reactivate when the immune system is compromised.
Current treatments mainly target one enzyme involved in viral replication, but drug-resistant strains have increasingly emerged, especially among vulnerable patients.
To address this, scientists have been developing helicase-primase inhibitors, drugs that block a different and equally critical step in the virus’s life cycle.
Also read: How daily black cumin may support healthier cholesterol
From frozen images to movement
Using cryogenic electron microscopy, the research team captured extremely detailed images of the viral enzyme while it was bound to these newer drugs.
This allowed them to see exactly how the medication locks the viral machinery into an inactive state.
To understand the process as it unfolds, the scientists also used optical tweezers, a technology that employs focused laser beams to manipulate and monitor individual molecules.
This made it possible to watch the virus unwind its DNA and then observe the precise moment when the drug halted the process.
Also read: Dry January: A month without alcohol that can help build new habits
Together, these techniques provided both structural detail and dynamic insight, revealing not just what happens, but how it happens.
Why the findings matter
The study helps explain why these emerging antivirals may succeed where older drugs fail.
By targeting a different component of viral replication, they offer new options for treating infections that no longer respond to standard therapy.
The findings may also extend beyond herpes. Many DNA-based viruses rely on similar replication mechanisms, meaning the insights could guide future antiviral development more broadly.
Also read: Certain jobs may increase miscarriage risk, new Danish study finds
Key implications include:
- clearer understanding of antiviral resistance
- identification of new drug targets
- improved design of next-generation antiviral therapies
While clinical applications will take time, the ability to watch antiviral drugs stop a virus at the molecular level marks a significant step forward.
For patients with limited treatment options, this deeper understanding could shape the future of antiviral medicine.
Source: News Medical
Also read: Try this relaxing exercise before bed for a more restful night